Advances in molecular mechanism of gastric cancer peritoneal metastasis
World Journal of Gastrointestinal Oncology · 25.05.2026
DOI: 10.4251/wjgo.121799 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Oncology, online erschienen am 25.05.2026. Verfasst von Hai-Qing Yan und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Peritoneal metastasis represents one of the most frequent patterns of metastasis in gastric cancer and is associated with an exceedingly poor prognosis, demonstrated by a five-year survival rate of less than 2%. While treatment options remain limited for affected patients, advances in targeted therapy and immunotherapy continue to emerge. In this review, we synthesize published molecular biology research to summarize the diverse mechanisms underlying gastric cancer peritoneal metastasis. Our aim is to enhance the understanding of this process and to identify key molecules, signaling pathways, and cellular immune components involved, thereby offering new perspectives for precise diagnosis and treatment.
Zitieren
APA
Yan, H., Lai, Q., Huang, M., Wang, T., Wu, L., & Qin, Y. (2026). Advances in molecular mechanism of gastric cancer peritoneal metastasis. World Journal of Gastrointestinal Oncology. https://doi.org/10.4251/wjgo.121799
Vancouver
Yan H, Lai Q, Huang M, Wang T, Wu L, Qin Y. Advances in molecular mechanism of gastric cancer peritoneal metastasis. World Journal of Gastrointestinal Oncology. 2026. doi:10.4251/wjgo.121799
BibTeX
@article{Yan2026,
author = {Yan, Hai-Qing and Lai, Qin-Qiao and Huang, Ming-Wei and Wang, Ting-An and Wu, Liu-Cheng and Qin, Yu-Zhou},
title = {Advances in molecular mechanism of gastric cancer peritoneal metastasis},
journal = {World Journal of Gastrointestinal Oncology},
year = {2026},
doi = {10.4251/wjgo.121799}
}
EUVIMED